Clinical Trial Update: Safety and Tolerability of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update reporting on the safety and tolerability of vortioxetine (Lu AA21004) in adults with major depressive disorder; results were poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Vortioxetine (vortioxetine)

Snippet

Sponsor: Takeda | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2013-12-13